Pharmacovigilance Polaris Alpha

Access and review therapeutic indications and adverse reactions reported on Summary of Product Characteristics (SmPCs) encoded as MedDRA Lowest Level Terms (LLTs).

This product is under development and will be released in summer 2023. In the meantime, you may contact us to know more about our data integration service for encoding your own SmPC data set.